Seattle — April 9, 2026 — Fred Hutch Obliteride, Fred Hutch Cancer Center’s annual bike ride and 5K walk/run to support cancer research and care, is now open for registration. The ride and 5K will take place on Saturday, Aug. 8, starting at University of Washington and ending at Gas Works Park.
“Obliteride is more than an event — it’s a movement of people who refuse to wait for a world without cancer. Every rider, runner, walker, and supporter shows up with purpose, proving that when we come together with courage and momentum, we can accelerate cures faster,” said Tracy Evans, senior executive director of Obliteride.
Ready, set, raise research funding!
Now in its 14th year, Obliteride has raised more than $67 million and included 41,000 participants since it launched in 2013. This year, organizers hope to raise more than $10 million and engage more than 5,700 participants.
“For more than 50 years, the Obliteride community has powered Fred Hutch’s breakthroughs,” said Evans. “Their commitment shows what’s possible when a community comes together to take action.”
To date, Obliteride funds have fueled new approaches for breast, colon, pancreatic, prostate and other cancers; community partnerships that improve public health; therapies that retrain the body’s immune cells to attack cancers; and insights into diet, genetics and cancer risk.
“The flexible funding Obliteride provides has made such a powerful impact on my research,” said Dr. Nina Salama, Fred Hutch professor of human biology and public health sciences and holder of the Dr. Penny E. Petersen Memorial Chair for Lymphoma Research. “I look forward to participating in Obliteride every year, and every day I see the impact this event has on research around Fred Hutch.”
Participants can ride a 25-, 50- or 100-mile bike route, complete a 5K walk/run, or participate virtually. Every dollar raised fuels scientific discovery at Fred Hutch, thanks to event sponsors and supporters. Participants can also choose to fundraise for a particular area of research that is most meaningful for them.
Community comes together
“Immunotherapy and bone marrow transplantation were lifesaving therapies for me after my cancer diagnosis. Bone marrow transplantation was developed right at Fred Hutch,” said Danielle Bigler, wife, mother and cancer survivor. “I am alive and here today because of the treatment I received from my care team at Fred Hutch and those who dedicate their lives to cancer research.”
As part of Obliteride Weekend, participants are invited to a Friday night party at Gas Works Park on Aug. 7, featuring food, live entertainment, and a chance to connect with other cyclists, runners, walkers and volunteers. The main event on Aug. 8 begins at 6:30 a.m. with route start times based on participation type and distance. The family-friendly 5K begins at 8:00 a.m.
For a limited time this spring, participants who register will receive 50% off their registration fee. Registration will remain open until Saturday Aug. 8. To learn more, sign up or donate, visit Obliteride.org.
##
Media Contact:
Kat Wynn
kwynn@fredhutch.org
Fred Hutchinson Cancer Center
Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program.